Prescription Drug News and Research RSS Feed - Prescription Drug News and Research

Loyola University Health System to hold medication take-back day

Loyola University Health System to hold medication take-back day

Loyola University Health System will partner with the Cook County Sheriff's Department to hold a medication take-back day. [More]
NIH announces 11 awards to improve public health outcomes related to substance use, addiction

NIH announces 11 awards to improve public health outcomes related to substance use, addiction

More than $11 million over three years will be used to support research exploring the use of social media to advance the scientific understanding, prevention, and treatment of substance use and addiction. [More]
Genome Canada awards $6M grant to CAMH and Assurex Health

Genome Canada awards $6M grant to CAMH and Assurex Health

Assurex Health and Canada's Centre for Addiction and Mental Health (CAMH) today announced they have received a $6 million grant from Genome Canada, an agency of the Canadian government, to study the benefits of genetic testing to guide medication decisions for patients with depression or schizophrenia. [More]
Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%. [More]
Medicare Advantage plans marked by shortcomings

Medicare Advantage plans marked by shortcomings

The New York Times reports that these problem areas include rejection of claims for medical services and limits on prescription drug coverage. News outlets also report on ACOs grades and Medicare Advantage rate shifts. [More]
Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3 isavuconazole VITAL study being presented at IDWeek on October 10, 2014, in Philadelphia, Pa. [More]
Connecture launches private health insurance exchange solution, On Ramp

Connecture launches private health insurance exchange solution, On Ramp

Connecture, Inc. ("Connecture"), a leading provider of web-based information systems used to create health insurance marketplaces, today announced the immediate availability of On Ramp, a full service, private health insurance exchange solution and corresponding benefits portal that provides the functionality needed to dramatically enhance the delivery of employee benefits and empower consumers to make more informed health insurance decisions with ease. [More]
Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Acacia Pharma announces positive Phase 3 results with APD421 for the management of post-operative nausea & vomiting (PONV). The data generated demonstrated a statistically significant reduction in the incidence of PONV with APD421 compared to placebo in adult surgical patients at moderate to high risk of suffering PONV (PONV is defined as any episode of emesis or use of antiemetic rescue medication in the first 24 hours after surgery). [More]
Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies. [More]
State highlights: Fla. toughens drug compounding laws; Conn. hospitals leave largest insurer

State highlights: Fla. toughens drug compounding laws; Conn. hospitals leave largest insurer

A selection of health policy stories from Florida, Connecticut, New York, Michigan, Louisiana, Pennsylvania and Arkansas. [More]
Agingcare.com introduces Prescription Drug Assistance Locator tool

Agingcare.com introduces Prescription Drug Assistance Locator tool

Paying for prescription medications just got easier for families who frequent AgingCare.com, the go-to destination for family caregivers. [More]
AAN releases new position statement on opioids for chronic non-cancer pain

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain. [More]

CVS to pay $6M to settle Medicaid reimbursement case

Caremark LLC, a unit of CVS, will make the payments to settle allegations that it knowingly failed to reimburse Medicaid for prescription drug costs paid on behalf of patients who were also covered by private plans it administered. The company denied wrongdoing. [More]
CVS/pharmacy renews Medication Disposal for Safer Communities donation program

CVS/pharmacy renews Medication Disposal for Safer Communities donation program

CVS/pharmacy announced today that is marking National Prescription Drug Take Back Day on Saturday, September 27 by renewing its innovative community donation program to support local drug collection efforts by law enforcement. [More]
IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

IGI Laboratories, Inc., a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and records for 18 drug products from AstraZeneca, 17 of which were marketed. [More]

Capital Bluecross encourages people to make use of National Prescription Drug Take-Back Day

To support a nationwide effort to clear homes of potentially dangerous, expired, unused and unwanted prescription drugs, Capital BlueCross is reminding residents to take advantage of the Drug Enforcement Administration's (DEA) National Prescription Drug Take-Back Day from 10 a.m. to 2 p.m. Saturday, Sept. 27. Take-Back Day collection is free and anonymous. [More]
Teens around the world frequently use OTC and prescription medications without doctor's order

Teens around the world frequently use OTC and prescription medications without doctor's order

Adolescents around the world are frequently using over-the-counter and prescription medications without a doctor's order, a risky practice that can lead to overuse and abuse and is often continued into adulthood, reveals a new review in the Journal of Adolescent Health. [More]
Viewpoints: Ezekiel Emanuel's choice of an age to die; new enrollment numbers still confusing

Viewpoints: Ezekiel Emanuel's choice of an age to die; new enrollment numbers still confusing

Seventy-five. That's how long I want to live: 75 years. This preference drives my daughters crazy. It drives my brothers crazy. My loving friends think I am crazy. They think that I can't mean what I say; that I haven't thought clearly about this, because there is so much in the world to see and do. To convince me of my errors, they enumerate the myriad people I know who are over 75 and doing quite well. They are certain that as I get closer to 75, I will push the desired age back to 80, then 85, maybe even 90. I am sure of my position. [More]

New expert panel report on state of therapeutic products for children

A new expert panel report, Improving Medicines for Children in Canada, released today by the Council of Canadian Academies, addresses the importance of developing safe and effective medicines for children. [More]
Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Prescription drug abuse is an extremely complex problem with no single solution. For example, the very same medications that are so critical for alleviating pain in legitimate patients could easily be diverted and misused by other people. [More]